{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:20:02Z","timestamp":1758979202895},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1053\/ajkd.2003.50137","type":"journal-article","created":{"date-parts":[[2003,2,28]],"date-time":"2003-02-28T17:48:30Z","timestamp":1046454510000},"page":"e10.1-e10.6","source":"Crossref","is-referenced-by-count":10,"title":["Withdrawal of interferon-\u03b1 results in prompt resolution of thrombocytopenia and hemolysis but not renal failure in hemolytic uremic syndrome caused by interferon-\u03b1"],"prefix":"10.1053","volume":"41","author":[{"given":"Naro","family":"Ohashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiko","family":"Yonemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taisuke","family":"Isozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akashi","family":"Togawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihide","family":"Fujigaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Hishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/ajkd.2003.50137_bib1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1200\/JCO.1986.4.2.234","article-title":"Clinical toxicity of interferons in cancer patients: A review","volume":"4","author":"Quesada","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1053\/ajkd.2003.50137_bib2","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/1097-0142(19860415)57:8+<1709::AID-CNCR2820571315>3.0.CO;2-F","article-title":"Safety and tolerance of recombinant interferon alfa-2\u03b1 (Roferon-A) in cancer patients","volume":"57","author":"Jones","year":"1986","journal-title":"Cancer"},{"key":"10.1053\/ajkd.2003.50137_bib3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000187894","article-title":"Minimal-change glomerulopathy and glomerular visceral epithelial hyperplasia associated with alpha-interferon therapy for cutaneous T-cell lymphoma","volume":"67","author":"Traynor","year":"1994","journal-title":"Nephron"},{"key":"10.1053\/ajkd.2003.50137_bib4","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1002\/(SICI)1097-0142(19981101)83:9<1938::AID-CNCR9>3.0.CO;2-M","article-title":"Interferon-\u03b1 associated focal segmental glomerulosclerosis with massive proteinuria in patients with chronic myeloid leukemia following high dose chemotherapy","volume":"83","author":"Shah","year":"1998","journal-title":"Cancer"},{"key":"10.1053\/ajkd.2003.50137_bib5","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0272-6386(96)90389-3","article-title":"Focal segmental glomerulosclerosis with acute renal failure associated with \u03b1-interferon","volume":"28","author":"Coroneos","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2003.50137_bib6","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0272-6386(12)80682-2","article-title":"Membranoproliferative glomerulonephritis in a patient treated with interferon-\u03b1 for human immunodeficiency virus infection","volume":"24","author":"Kimmel","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2003.50137_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJM198401053100107","article-title":"Acute interstitial nephritis with the nephritic syndrome following recombinant leukocyte A interferon for mycosis fungoides","volume":"310","author":"Aberbuch","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2003.50137_bib8","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1681\/ASN.V5101740","article-title":"Rapidly progressive glomerulonephritis after immunotherapy for cancer","volume":"5","author":"Parker","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/ajkd.2003.50137_bib9","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.1053\/ajkd.2000.8304","article-title":"Renal thrombotic microangiopathy associated with interferon-\u03b1 treatment of chronic myeloid leukemia","volume":"36","author":"Magee","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2003.50137_bib10","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1002\/(SICI)1097-0142(19990615)85:12<2583::AID-CNCR14>3.0.CO;2-#","article-title":"Thrombotic microangiopathy associated with interferon therapy for patients with chronic myelogenous leukemia: Coincidence or true side effect?","volume":"85","author":"Ravandi-Kashani","year":"1999","journal-title":"Cancer"},{"key":"10.1053\/ajkd.2003.50137_bib11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0272-6386(97)90575-8","article-title":"Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myelocytic leukemia","volume":"30","author":"Honda","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/ajkd.2003.50137_bib12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ajh.2830460220","article-title":"Recombinant interferon alpha and hemolytic uremic syndrome: Cause or coincidence","volume":"46","author":"Harvey","year":"1994","journal-title":"Am J Hematol"},{"key":"10.1053\/ajkd.2003.50137_bib13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ajh.2830490124","article-title":"CML may not be part of HUS","volume":"49","author":"Lipton","year":"1995","journal-title":"Am J Hematol"},{"key":"10.1053\/ajkd.2003.50137_bib14","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ajh.2830470332","article-title":"Hemolytic-uremic syndrome in a patient with chronic myelogenous leukemia treated with interferon alpha","volume":"47","author":"Schlaifer","year":"1994","journal-title":"Am J Hematol"},{"key":"10.1053\/ajkd.2003.50137_bib15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000040993","article-title":"Thrombotic thrombocytopenic purpura during interferon alpha treatment for chronic myelogenous leukemia","volume":"102","author":"Lacotte","year":"2000","journal-title":"Acta Haematol"},{"key":"10.1053\/ajkd.2003.50137_bib16","first-page":"111","article-title":"Renal thrombotic microangiopathy in patients with chronic myelogenous leukemia treated with interferon-\u03b12b","volume":"10","author":"Jadoul","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2003.50137_bib17","first-page":"140","article-title":"Cancer- and drug-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome","volume":"34","author":"Gordon","year":"1997","journal-title":"Semin Hematol"},{"key":"10.1053\/ajkd.2003.50137_bib18","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1136\/bmj.298.6689.1713-b","article-title":"Autoimmune hemolytic anemia associated with interferon alfa-2a in a patient with mycosis fungoides","volume":"298","author":"Braathen","year":"1989","journal-title":"BMJ"},{"key":"10.1053\/ajkd.2003.50137_bib19","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1182\/blood.V64.3.592.592","article-title":"Abnormal VIII: von Willebrand factor patterns in the plasma of patients with the hemolytic-uremic syndrome","volume":"64","author":"Moake","year":"1984","journal-title":"Blood"},{"key":"10.1053\/ajkd.2003.50137_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(88)92287-8","article-title":"Lytic anti-endothelial cell antibodies in haemolytic-uraemic syndrome","volume":"2","author":"Leung","year":"1988","journal-title":"Lancet"},{"key":"10.1053\/ajkd.2003.50137_bib21","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1182\/blood.V60.4.1030.1030","article-title":"Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells","volume":"60","author":"Burns","year":"1982","journal-title":"Blood"},{"key":"10.1053\/ajkd.2003.50137_bib22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000203678","article-title":"Thrombotic microangiopathy in a patient with chronic myelogenous leukemia on hydroxyurea","volume":"97","author":"Shammas","year":"1997","journal-title":"Acta Haematol"},{"key":"10.1053\/ajkd.2003.50137_bib23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0022-2143(98)90159-7","article-title":"Interferon-\u03b1 restores \u03b21-dependent, collagen-mediated platelet aggregation in a patient with chronic myelogenous leukemia","volume":"131","author":"Verfaillie","year":"1998","journal-title":"J Lab Clin Med"},{"key":"10.1053\/ajkd.2003.50137_bib24","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1001\/archinte.159.21.2524","article-title":"Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention","volume":"159","author":"Bennett","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1053\/ajkd.2003.50137_bib25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura: Canadian Apheresis Study Group","volume":"325","author":"Rock","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2003.50137_bib26","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/ajkd.2003.50137_bib27","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome","volume":"339","author":"Furlan","year":"1998","journal-title":"N Engl J Med"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638602692443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638602692443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T23:02:51Z","timestamp":1622847771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638602692443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["S0272638602692443"],"URL":"https:\/\/doi.org\/10.1053\/ajkd.2003.50137","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2003,3]]}}}